This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Find out more here.
Cost-effectiveness and Quality of Life of Laparoscopic Ileocecal Resection Versus Infliximab of Active Terminal Ileitis in Crohn’s Disease: a Randomized Controlled Trial
Posted in Lectures on 1 February 2018

Willem Bemelman
Department of Gastroenterology and Surgery
Academic Medical Center, Amsterdam, The Netherlands